Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials.
about
Homocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine-lowering interventions for preventing cardiovascular eventsHomocysteine lowering interventions for preventing cardiovascular eventsGenome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrationsIdentification of differentially expressed proteins in blood plasma of control and cigarette smoke-exposed mice by 2-D DIGE/MS.Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease.Nutraceuticals and headache: the biological basis.Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at RiskNutritional B vitamin deficiency alters the expression of key proteins associated with vascular smooth muscle cell proliferation and migration in the aorta of atherosclerotic apolipoprotein E null miceThe annexin A2 system and vascular homeostasisA sulfur amino acid-free meal increases plasma lipids in humansThe methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism.Differential effects of nutritional folic acid deficiency and moderate hyperhomocysteinemia on aortic plaque formation and genome-wide DNA methylation in vascular tissue from ApoE-/- mice.The effect of soy or isoflavones on homocysteine levels: a meta-analysis of randomised controlled trials.Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo.A long and winding road: defining the biological role and clinical importance of paraoxonases.Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interactionEnhancing the health-promoting effects of tomato fruit for biofortified foodEpigenetic modifications and human pathologies: cancer and CVD.Novel metabolic biomarkers of cardiovascular disease.Homocysteine-lowering interventions for preventing cardiovascular events.Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia.Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.Comment on Rubino et al., 'Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis'.Reduction of homocysteine in elderly with heart failure improved vascular function and blood pressure control but did not affect inflammatory activity.Sodium hydrosulfide attenuates hyperhomocysteinemia rat myocardial injury through cardiac mitochondrial protection.Plasma total homocysteine level and its association with carotid intima-media thickness in obesity.Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects.Methionine-supplemented diet affects the expression of cardiovascular disease-related genes and increases inflammatory cytokines in mice heart and liver.Translational Aspects of Sphingolipid Metabolism in Renal Disorders.Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.Relationship between plasma total homocysteine level and dietary caffeine and vitamin B6intakes in pregnant women
P2860
Q24186605-66F4F34B-28FC-4EE7-961C-3E0F51F12508Q24201783-E91AF305-C5A5-4B3C-A7FE-830ECDFAD41EQ24239981-818D69E3-BB57-486B-930E-C757369E6A6FQ24644637-A33F55EC-36E8-49C4-B5CA-93B54F1C3D27Q33815416-59A574BD-0D1A-42EA-AB4E-98EF39939E76Q33915599-11BDE0A5-5E86-4DB0-80DA-56AAA1642E72Q34166931-EE78E5B7-60DE-4236-A48D-5D775586C7C6Q34516430-DFCCFB49-32F7-4736-B27C-ADEC9C784A90Q34603680-36568251-A5DD-45E0-87F0-657845F87D8AQ35028300-E6B6BC6F-FFCA-4F78-8F6D-7D2D96727A8DQ35112064-58CB2B7A-39BD-4561-8BF6-325958A66DE2Q35752594-E8B7E9C5-C93C-42D7-A123-D38EB45C38D3Q36002493-148FB307-D5CE-4212-901D-FF5FD93DA32CQ36026664-AE2976CE-5BF0-4238-9F54-A085066090ADQ36445448-46F2A0C4-08FD-40B6-9515-00FD240C1FD4Q36588161-4590F13F-BE9F-454F-917C-9E9F526DBABCQ37104293-DA66A8A3-043C-482E-B07D-D19EC307E779Q37679678-652F8C62-55E4-4878-ADAB-0A87E4D2F76DQ37808514-7675852F-FDC6-4E3A-AEDD-69FBF9CCFD7BQ38245327-83C60AE4-53CA-4C48-B545-1D816022CE1DQ38620630-A640F0F3-EC9B-4613-9299-B93F00FF7A68Q39225879-7E095967-5941-4E73-90F7-30ABB8C50307Q42595647-5923035C-41F8-41FC-8A4C-76F7EEC14273Q45928624-ADFBF412-EE47-4F04-B688-DF90FAD24042Q46762950-3BBAAD40-C81C-4228-9552-EB8BDDCC8F59Q46817216-362B6A06-1B09-4874-A957-519A80A9BF49Q46898775-92336240-0872-452D-AE83-A3F1F2CE59E4Q46954618-3C56FDD6-A43D-4EC3-ACF9-62161170A639Q47842760-16EA949E-80FE-4363-99DE-93AF78EF445AQ49399657-A047BDBF-0AAC-46E0-A0AA-95EFE7EAE401Q53515835-49D0FFA4-0756-4D39-9EE3-078973FD3082Q56761935-5DEF9FA1-F021-4089-BEA2-8587FBCDABEB
P2860
Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Homocysteine and cardiovascula ...... he need for randomized trials.
@ast
Homocysteine and cardiovascula ...... he need for randomized trials.
@en
type
label
Homocysteine and cardiovascula ...... he need for randomized trials.
@ast
Homocysteine and cardiovascula ...... he need for randomized trials.
@en
prefLabel
Homocysteine and cardiovascula ...... he need for randomized trials.
@ast
Homocysteine and cardiovascula ...... he need for randomized trials.
@en
P2093
P1476
Homocysteine and cardiovascula ...... he need for randomized trials.
@en
P2093
Adam Splaver
Charles H Hennekens
Gervasio A Lamas
P356
10.1016/J.AHJ.2004.02.004
P407
P577
2004-07-01T00:00:00Z